Article thumbnail

Phase II Pilot Clinical Trial of Pazopanib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When No Intensive Treatment Is Possible

By Torsten Kessler, Steffen Koschmieder, Hartmann Wolfgang, Eva Wardelmann, Eike Bormann, Joachim Gerss, Tim Henrik Brümmendorf, Carsten Mueller-Tidow, Wolfgang E. Berdel, Christoph Schliemann, Martina Crysandt, Jan-Henrik Mikesch, Matthias Stelljes, Linus Angenendt, Georg Lenz, Anna Kirsch and Kerstin Vehring
Topics: info:eu-repo/classification/ddc/610
Publisher: 'American Society of Hematology'
Year: 2018
DOI identifier: 10.1182/blood-2018-99-118095
OAI identifier: oai:publications.rwth-aachen.de:756194
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://publications.rwth-aach... (external link)
  • https://publications.rwth-aach... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.